PHOTOTHERAPY systems
Foot Phototherapy- NEW!
Dermawand - wound care
Related products
TRU-BLU acne treatment - NEW!
Replacement Lamps/Bulbs 
Measuring Devices  
Eye Protection
PRESCRIBING PHOTOTHERAPY
Phototherapy vs Biologics
PUVA - UVA plus Psoralen
NB UVB vs PUVA vitiligo study
Blue Lights for Acne
Blue Light Studies Prove Value
Scalp Psoriasis Treatment 
Narrowband UVB phototherapy
PHYSICIAN DISCOUNTS
SUPPORTING YOUR PATIENTS
Medicare Reimbursement
Insurer Coverage and Payouts
Letter of Medical Necessity
PHOTOTHERAPy in practice
Adding Phototherapy to Practice
Pediatric Dermatology
Psoriasis Patients Underserved
Phototherapy for Podiatry
Small Units for Small Patches
Patient HOME UNITS
Full Body Folding Unit  
Handheld Spot Treatment 
Home UVB Light Panels
Efficacy of Home Phototherapy
Cost of At-Home Phototherapy
NEWS
NYT: Psoriasis drugs hit ceiling
Biologics cost more than house
State of phototherapy training
Upcoming Trade Shows
ABOUT NATIONAL BIOLOGICAL
Hear From Our Customers
On-site Manufacturing Facility
Current Research and Links
About Us
NEED HELP?
Site Map
Contact Us
800-338-5045

 


PATIENTS     PHYSICIANS     THIRD PARTY PAYERS     HOME    

Blue Lights are Effective Treatment for Acne                 Read about Tru-Blu™

     A review of the literature
                                                                                                                        What are Blue Lights?

#1 An open study to determine the efficacy of blue light in the treatment of mild to moderate acne. Morton CA, Scholefield RD, Whitehurst C, Birch J. J Dermatolog Treat 2005; 16:219-23.
BACKGROUND: The rise in antibiotic resistance threatens to reduce the future usefulness of the current mainstay of therapy. Phototherapy has previously been shown to be effective in acne, with renewed interest as both endogenous and exogenous photodynamic therapies are demonstrated for this condition. OBJECTIVES: To determine the effect of narrowband blue light in the reduction of inflammatory and non-inflammatory lesions in patients with mild to moderate acne and to evaluate patient tolerance of the therapy. METHODS: We performed an open study utilizing a blue LED light source in 30 subjects with mild to moderate facial acne. Over 4 weeks, patients received eight 10- or 20-minute light treatments, peak wavelength 409-419 nm at 40 mW/cm2. Assessments were taken at weeks 5, 8 and 12 and lesion counts were recorded. Repeated measures-ANOVA and Dunnett's tests, respectively, allowed assessment of the different scores over time and permitted comparison of mean counts. RESULTS: An overall effect on inflammatory counts was observed at week 5, and a statistically significant decrease in inflamed counts was detected at the week 8 assessments, which continued to week 12. There was little effect on non-inflamed lesions. The treatment was well tolerated with adverse events experienced generally rated as being mild and usually self-limiting. CONCLUSIONS: Eight 10- or 20-minute treatments over 4 weeks with a narrowband blue light was found to be safe and  effective in reducing the number of inflamed lesions in subjects with mild to moderate acne. The treatment had little effect on the number of comedones. The onset of the effect was observable at the first assessment, at week 5, and maximal between weeks 8 and 12.
#2 The effective treatment of acne vulgaris by a high-intensity narrow band 405-420nm light source.Elman M, Slatkin M, Harth Y. J Cosmet Ther 2003; 5:111-7.
BACKGROUND: Available topical treatments are slow and frequently irritating. Oral therapies may be associated with increased bacterial resistance (antibiotics) or possible severe side effects (oral isotretinoin). In vitro and in vivo exposure of acne bacteria to 405-420 nm ultraviolet (UV) free blue light results in the photo-destruction of these bacteria through the effects on the porphyrins produced naturally by Propionibacterium acnes. A novel, high-intensity, narrow band 420 nm UV free blue light has been shown to decrease inflammatory acne lesions after eight bi-weekly treatments. OBJECTIVES: To examine the effects of high-intensity, narrow band 420 nm UV free blue light (ClearLight) on inflammatory acne lesions. METHODS: Three studies were carried out to examine the clinical effects of high-intensity, narrow band blue light on papulo-pustular acne: the split-face dose-response study, the full-face open trial and the split-face, double-blind controlled study. The studies enrolled 10, 13 and 23 patients respectively. RESULTS: The data show more than an 80% response to 420 nm acne phototherapy with a significant reduction of 59-67% of inflammatory acne lesions after only eight treatments of 8-15 minutes. The reduction in lesions was steady in the follow-ups at 2, 4 and 8 weeks after the end of therapy. Prolonged remission was evident in the 8 weeks after the end of therapy. No adverse effects or patient discomfort were noted in any of the patients.
CONCLUSIONS
: Acne phototherapy by high intensity, narrow band 405-420 nm light is proven to be an attractive, fast, effective, non-invasive alternative to current topical and parenteral anti-acne remedies.
#3 Blue light phototherapy in the treatment of acne. Tzung TY, Wu KH, Huang ML. Photodermatolog, Photoimmunol & Photomed, 2004 Aug; 20, 266-9

BACKGROUND: Blue light irradiation is known to be effective against acne. However, the profile of a good candidate is still unclear. METHODS: Thirty-one Taiwanese with symmetrical facial acne were irradiated with blue light on one side of the face selected randomly twice weekly for 4 consecutive weeks. The other half of the face was left untreated as control. Parameters, including scar type, pore size, and facial follicular porphyrin fluorescence intensity, were documented. The severity of acne was assessed before the treatment, after two, four, and eight sessions of treatment, and 1 month after the treatment was completed. RESULTS: Compared with the non-irradiation side, eight sessions of blue light irradiation were effective in acne treatment (P<0.001). Gender (P=0.471), scar type (P-values of pitted, atrophic, and hypertrophic type were 0.688, 0.572, and 0.802, respectively), pore size (P=0.755), and pretreatment fluorescence intensity (P=0.656) could not be used as predictive factors of therapeutic effectiveness. Compared with pretreatment, nodulocystic lesions tended to worsen despite treatment. In addition, the therapeutic effectiveness was not related to the fluorescence intensity change (P=0.812).
CONCLUSIONS
: Blue light irradiation is effective in acne treatment. Patients without nodulocystic lesions are better candidates for blue light irradiation.

#4  Acne Phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. J Dermatol Sci 2002; 30:129-35.
The purpose of this study was to investigate the efficacy of phototherapy with a newly-developed high-intensity, enhanced, narrow-band, blue light source in patients with mild to moderate acne. An open study was performed in acne patients who were treated twice a week up to 5 weeks. Acne lesions were reduced by 64%. Two patients experienced dryness. No patient discontinued treatment due to adverse effects. In vitro investigation revealed that irradiation from this light source reduced the number of Propionibacterium acnes (P. acnes), but not Staphylococcus epidermidis that were isolated from the acne patients. Phototherapy using this blue light source was effective and well tolerated in acne patients and had an ability to decrease numbers of P. acnes in vitro, suggesting that this phototherapy may be a new modality for the treatment of acne.

Tru-Blu acne treatment:  TruBlu product info - tru-blu blue light info sheet - tru-blu acne research
Clinical UVA/UVB PhototherapyFoldalite-32 - Houva II - Houva III - Hand/Foot II - Tru-Blu
TM
Phototherapy for home use: Panosol II -- Dermalight80 - Foldalite III - Handisol - Hand/Foot II